Inhibition of CYP1A1 expression enhances diabetic wound healing by modulating inflammation and oxidative stress in a rat model
Tissue and Cell · 2024
DOI: 10.1016/j.tice.2024.102483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue and Cell, 2024. Verfasst von Jing-Chun Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hand Surgery, Wound Reconstructive Surgery, and Burn Surgery, Lishui People's Hospital, Lishui, Zhejiang 323000, China. Hauptthemen laut MEDLINE: Wound Healing, Oxidative Stress, Rats, Sprague-Dawley, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
OBJECTIVE: Wound therapies utilizing gene delivery to the skin offer considerable promise owing to their localized treatment benefits and straightforward application. This study investigated the impact of skin electroporation of CYP1A1 shRNA lentiviral particles on diabetic wound healing in a streptozotocin (STZ)-induced rat model. METHODS: Male Sprague Dawley (SD) rats were made diabetic by injecting STZ and subsequently creating foot skin wounds. The rats were randomly divided into four groups: normal, diabetic foot ulcers (DFU), DFU + control shRNA (electroporation of control shRNA lentiviral particles), and DFU + CYP1A1 shRNA (electroporation of CYP1A1 shRNA lentiviral particles). Wound healing progress was monitored at multiple time points (0, 1, 3, 5, 7, 10, 14 days). On day 14, wound tissue specimens were collected for histological examination. Wound samples collected at days 7 and 14 were used for gene expression analysis via qRT-PCR, assessment of CYP1A1 protein levels using western blotting, and evaluation of oxidative stress markers. RESULTS: Treatment with CYP1A1 shRNA significantly enhanced diabetic wound healing rates compared to untreated controls over the observation period. Histological analysis revealed improved wound characteristics in the CYP1A1 shRNA-treated group, including enhanced epithelial regeneration, reduced inflammation, and increased collagen deposition, indicative of improved tissue repair. Furthermore, suppression of CYP1A1 corresponded with decreased expression levels of pro-inflammatory cytokines (interleukin-1β, tumor necrosis factor-α, and interleukin-6) and diminished oxidative stress markers (malondialdehyde, superoxide dismutase) within wound tissues. CONCLUSION: Targeted suppression of CYP1A1 represents a promising therapeutic strategy to enhance diabetic wound healing by modulating inflammation and oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hand Surgery, Wound Reconstructive Surgery, and Burn Surgery, Lishui People's Hospital, Lishui, Zhejiang 323000, China.
- Department of Hand Surgery, Wound Reconstructive Surgery, and Burn Surgery, Lishui People's Hospital, Lishui, Zhejiang 323000, China. Electronic address: hemengqi30@163.com.
Zitieren
APA
Chen, J. C., & He, M. Q. (2024). Inhibition of CYP1A1 expression enhances diabetic wound healing by modulating inflammation and oxidative stress in a rat model. Tissue and Cell. https://doi.org/10.1016/j.tice.2024.102483
Vancouver
Chen JC, He MQ. Inhibition of CYP1A1 expression enhances diabetic wound healing by modulating inflammation and oxidative stress in a rat model. Tissue and Cell. 2024. doi:10.1016/j.tice.2024.102483
BibTeX
@article{Chen2024,
author = {Chen, Jing-Chun and He, Meng-Qi},
title = {Inhibition of CYP1A1 expression enhances diabetic wound healing by modulating inflammation and oxidative stress in a rat model},
journal = {Tissue and Cell},
year = {2024},
doi = {10.1016/j.tice.2024.102483}
}
EUVIMED